Overall assessment

Moms.gov is an official HHS public-facing site for new and expecting mothers. Its stated purpose is to provide “resources, information, and help” for mothers and fathers facing difficult or unexpected pregnancies. The site includes some medically useful links, especially to FQHCs, breastfeeding resources, maternal mental health support, Head Start, CDC pregnancy resources, and substance-use information. It also links directly to OptionLine as the pregnancy-center locator, which is the site’s major ethical and evidence problem. Moms.gov states that pregnancy centers may offer pregnancy tests, ultrasounds, STI testing, parenting support, childbirth classes, referrals, and material goods, and it says there are more than 2,750 pregnancy centers nationally. It does not state with equal prominence that the linked OptionLine network does not provide or refer for abortion services.

Subscribe now

From an evidence-based public health perspective, the site is not uniformly unreliable, but it is not neutral. It’s Ideological. It combines legitimate health resources with ideologically selected pregnancy-support pathways. That matters because a federal site carries institutional authority. When HHS links pregnant women to a pregnancy-center network that excludes abortion referral, the limitation should be explicit, prominent, and visible before the user leaves the government site.

Page-by-page / section-by-section critique

Home page: “Resources, Information, and Help for New and Expecting Mothers”

The opening frame is supportive but selective. It emphasizes unexpected pregnancy, mothers, fathers, family wellbeing, and “American families.” That framing is not medically wrong, but it is value-laden rather than clinically neutral. A federal pregnancy resource page should clearly distinguish medical care, social support, religious or ideological counseling, and non-referring pregnancy centers. Moms.gov does not do this adequately.

“Access Pregnancy Support Services and Health Centers”

This is the most important section. It links users to OptionLine to “Find Pregnancy Centers Near You.” The problem is not that pregnancy centers exist. Many provide diapers, clothing, peer support, parenting classes, and emotional support. The problem is that the linked network states that its participating centers offer peer counseling and information but do not offer or refer for abortion services. That disclosure appears on the OptionLine locator page, not prominently on Moms.gov before the referral. For a government website, that is a serious transparency failure.

A clinically honest version would say: “Pregnancy centers may provide free support and limited services, but many do not provide comprehensive reproductive health care and may not provide or refer for abortion.”

Federally Qualified Health Centers

This section is much stronger. Moms.gov links to HRSA’s FQHC locator and correctly describes FQHCs as serving medically underserved areas and providing primary care, maternal care, and prenatal care regardless of ability to pay. That is appropriate public health routing. Unlike pregnancy centers, FQHCs are medical-care entities with defined federal standards, clinical staff, and accountability structures.

This section should be placed before the pregnancy-center locator, or at least presented as the primary route for medical care.

Nutrition quick facts

The basic nutrition advice is broadly reasonable: folic acid, nutrient-dense foods, iron-rich foods, folate-rich greens, legumes, eggs, dairy, and low-mercury omega-3 seafood. The CDC folic acid recommendation of 400 micrograms daily is consistent with standard public health guidance.

Share

The linked “Dietary Guidelines for Americans 2025–2030” document, however, has a strongly political and ideological tone. It uses phrases such as “Make America Healthy Again” and frames nutrition policy as a major political reset. That language is not ideal for a government clinical resource aimed at pregnant women. Nutrition advice should be evidence-based, practical, and nonpartisan.

“Jumpstart your child’s future with Trump Accounts”

This section is not a health resource. It is a financial-policy promotion embedded in a maternal health page. Even if the program is legal and available, its placement on a pregnancy health resource site blurs public health communication with political branding. It does not belong in a clinical or pregnancy-support information pathway.

“Looking to start a family?” / TrumpRx

This section links fertility-related medication access to TrumpRx. It includes a reasonable warning to talk with a qualified clinician before starting medications for weight management or fertility. But the section is clinically thin. Fertility evaluation requires more than medication pricing. It should address age, ovulatory function, semen analysis, tubal factors, endometriosis, PCOS, diabetes, obesity, thyroid disease, and timing of referral.

As written, it feels more like a promotional link than a complete preconception or infertility resource.

Preconception health

This is one of the better sections. It correctly states that addressing chronic disease and identifying risk factors can improve pregnancy outcomes. The reference to preconception health is appropriate. However, the section then highlights fertility awareness-based methods. FABMs can help some women identify fertile windows and cycle irregularities, but they are not a substitute for clinical evaluation when infertility, irregular menses, PCOS, endometriosis, recurrent pregnancy loss, diabetes, hypertension, or advanced reproductive age are present.

The section should be expanded to include folic acid, medication review, diabetes optimization, hypertension management, vaccination, substance use, genetic carrier screening when appropriate, and timing of referral.

Breastfeeding information

The breastfeeding section links to established federal resources and correctly states that breastfeeding has benefits but can be difficult. This is reasonable. The language “breastmilk is the perfect food” is common in public health messaging, but it can be emotionally loaded for women who cannot breastfeed, have low milk supply, need medication, have trauma, return to work early, or choose formula.

A more balanced message would support breastfeeding while clearly stating that safe formula feeding is medically appropriate when breastfeeding is not possible or not chosen.

Subscribe now

Infant and toddler nutrition

This section is generally appropriate. It recommends exclusive breastfeeding for about 6 months, iron-fortified infant formula when breast milk is not available, introduction of solid foods at about 6 months, and continued breastfeeding as mutually desired. It also acknowledges formula safety and FDA testing.

The one concern is tone. It should avoid implying that formula is second-best in a moral sense. Clinically, the key issue is safe, adequate infant nutrition.

Mental health resources for mothers

This section is strong. It states that postpartum depression affects about 1 in 8 women and gives the maternal mental health hotline, 1-833-TLC-MAMA, plus 988 for suicidal crisis. That is appropriate, concrete, and potentially lifesaving.

The section would be stronger if it also mentioned anxiety, OCD, PTSD after traumatic birth, postpartum psychosis, intimate partner violence, and the need for urgent care when there are thoughts of self-harm, harm to the baby, mania, psychosis, or inability to sleep.

Adoption resources

This section is highly selective. Moms.gov links to Lifeline Adoption, Focus on the Family, and BraveLove. These may provide adoption-related support, but the selection is not neutral. Adoption counseling should include independent legal advice, grief counseling, coercion safeguards, financial-conflict disclosure, birth-parent rights, revocation periods, and state-specific law.

A federal site should not present ideologically aligned adoption resources without also linking to neutral legal, social work, and state child-welfare resources.

Early Head Start

This section is appropriate and evidence-aligned in concept. It lists prenatal education, nutrition support, parenting education, maternal mental health screening, home visiting, and care coordination. These are legitimate supports for low-income pregnant women and families.

This is one of the best parts of the site because it routes users toward structured public programs rather than ideologically filtered counseling.

Additional resources

The additional resources section is mostly useful. It links to child welfare, safe sleep, CDC pages on tobacco, alcohol, cannabis, STIs, toxoplasmosis, HIV, diabetes, gestational diabetes, hypertension, depression, medication use, emergency preparedness, workplace reproductive health, environmental health, and radiation exposure. These are appropriate topics for a maternal-health portal.

The weakness is organization. The page mixes solid clinical public health resources with political branding and ideologically selected pregnancy-center pathways. That mixture reduces trust.

Moms.gov Conscience Overview PDF

This PDF is the most ideologically explicit part of the site. It frames pregnancy, childbirth, newborn care, vaccines, pediatric services, end-of-life care, and refusal of treatment through “conscience protections.” It explains that federal law protects both families and health care entities in certain settings when religious beliefs or moral convictions shape care decisions. It also emphasizes provider, plan, trainee, and institutional protections for declining to perform, assist with, pay for, cover, or refer for certain services, including abortion and sterilization.

This is not ordinary patient education. It is a rights-and-refusal document centered on religious and moral objection. Some of the legal information may be accurate, but the ethical balance is incomplete. A patient-facing maternal health site should also explain the patient’s right to medically indicated care, emergency stabilization, evidence-based counseling, referral pathways, and freedom from abandonment. It should not elevate institutional conscience without equal attention to patient access, safety, and informed consent.

Bottom line

Moms.gov is not simply a bad website. It contains useful links to FQHCs, breastfeeding support, maternal mental health services, Early Head Start, CDC pregnancy resources, and infant nutrition guidance. Those are legitimate public health resources.

But the site has a major ethical flaw: it places ideologically selected pregnancy-center referrals inside an official federal maternal-health resource without making the non-referral limitation clear enough. It also embeds political branding and conscience-protection framing into what should be a clinically neutral pregnancy resource.

The concise peer-review conclusion would be:

Moms.gov provides some valid maternal and child health resources, but it fails as a neutral government pregnancy-information portal because it mixes evidence-based public health links with politically branded programs, ideologically selected adoption and pregnancy-center referrals, and an explicit conscience-rights framework. Pregnant women deserve public resources that clearly distinguish medical care from peer support, evidence-based counseling from ideological counseling, and comprehensive reproductive health services from non-referring pregnancy centers.

That is why https://optionline.org/ deserves careful review.

OptionLine presents itself as a pregnancy help service for women facing an unintended pregnancy. It offers phone, text, chat, and referral to local pregnancy centers. On the surface, this appears helpful. The problem is not that support exists. The problem is that the support is not clinically neutral, while the language often sounds like neutral pregnancy-options counseling.

It’s Ideological:

Ideological, in this context, means that the information is shaped by a prior moral, religious, or political position rather than by balanced clinical evidence and patient-centered informed consent. The problem is not that an organization has values. The problem is when those values determine which medical options are emphasized, minimized, delayed, or excluded while the service presents itself as neutral counseling.

Subscribe now

The most important disclosure on the site is that OptionLine and its participating pregnancy centers provide peer counseling and information about pregnancy options, but “do not offer or refer for abortion services.”

That matters.

A woman who is considering abortion may believe she is entering a neutral counseling pathway. In reality, she is being routed into a network that has already excluded one legal medical option from referral.

From a peer-review perspective, this is a major limitation in counseling validity.

The site provides some accurate basic information. It correctly notes that missed periods can occur for reasons other than pregnancy. It correctly encourages pregnancy testing. It correctly states that ultrasound can assess viability and help identify ectopic pregnancy. These are reasonable points.

But the site repeatedly overstates the role of ultrasound by suggesting that only ultrasound can confirm pregnancy. That is not clinically accurate. A positive urine or serum hCG test confirms biochemical pregnancy. Ultrasound confirms location, gestational age, and viability when clinically indicated. This distinction matters because overstating the need for ultrasound can delay care, especially abortion care, where time affects access, cost, legal options, and procedural choices.

The abortion-related pages are the most concerning. They frame abortion as a “big decision” requiring confirmation, reflection, and awareness of risk. None of that is inherently wrong. Every medical decision deserves informed consent. But informed consent requires balanced information. The site emphasizes abortion risk, possible emotional harm, and the need for safety checks, while giving far less attention to the medical risks of continuing pregnancy, childbirth, delayed abortion access, or coercive counseling.

This is not balanced risk communication. It is selective risk framing.

The medication abortion page identifies mifepristone and misoprostol, but uses language such as “chemical abortion” and describes progesterone reduction in emotionally charged terms. It also implies that ultrasound is generally needed before medication abortion. That is not consistent with contemporary evidence-based care. ACOG states that medication abortion through 70 days of gestation is safe and effective, and that ultrasound is not always required when gestational age and ectopic pregnancy risk can be assessed clinically.¹

The surgical abortion page is also problematic. It describes aspiration and dilation procedures, but uses language that emphasizes fetal removal and retained “fetal body parts.” That is not standard patient-centered clinical language for early aspiration abortion. It may be technically related to later procedural concerns, but the emphasis is disproportionate and emotionally weighted.

Share

The emergency contraception page raises another major evidence issue. It claims emergency contraception may prevent implantation or act as an abortifacient. The best available evidence does not support that claim for levonorgestrel emergency contraception. Current evidence indicates that levonorgestrel emergency contraception works mainly by delaying or inhibiting ovulation and does not show a meaningful post-ovulatory anti-implantation effect.² ³

The adoption and parenting pages are more supportive in tone, but they are still incomplete. Adoption is presented largely as a structured option, with open, semi-open, and closed models. Yet the page gives insufficient attention to grief, legal finality, possible coercion, agency incentives, and the need for independent counseling. Parenting is presented with offers of support, but without enough discussion of medical risk, housing insecurity, intimate partner violence, financial hardship, postpartum depression, or access to obstetric care.

The “after abortion support” material is somewhat more balanced, because it acknowledges that women may feel relief, sadness, regret, or mixed emotions. That is closer to real clinical experience. However, the broader implication that abortion commonly causes delayed psychological harm is not supported by high-quality evidence. Mental health outcomes after abortion are strongly shaped by prior mental health, stigma, coercion, intimate partner violence, social support, and life circumstances. Abortion itself should not be presented as a general cause of long-term mental health harm.⁴

The ethical problem is transparency.

Subscribe now

Pregnant women deserve help. They deserve kindness. They deserve time to think. They deserve support with parenting, adoption, abortion, prenatal care, housing, safety, insurance, and mental health. But they also deserve to know whether the person or organization counseling them is neutral, medical, religious, ideological, peer-based, anti-abortion, or non-referring.

A public pregnancy resource pathway should not blur those categories.

If a government website lists or amplifies pregnancy resources, it should apply basic quality standards.

First, pregnancy information should be medically accurate.

Second, abortion, contraception, and emergency contraception content should reflect mainstream evidence.

Third, counseling services should clearly disclose what they do and do not provide before a woman shares personal information.

Fourth, non-referral for abortion should be stated prominently, not buried in a disclaimer.

Fifth, public agencies should distinguish peer support from medical care.

This is not about whether pregnancy centers should exist. They can provide material help, emotional support, parenting resources, and community assistance. The issue is whether they should be presented within government-linked pregnancy resources without a clear, evidence-based warning that they do not provide or refer for abortion care.

In clinical medicine, we would not call a consultation neutral if one legal, evidence-based option had been removed before the patient entered the room.

Public health communication should meet the same standard.

Pregnant women do not need filtered information. They need accurate information. They do not need ideological navigation disguised as options counseling. They need transparent pathways to qualified care.

That is the standard government pregnancy resources should meet.

Page-by-page evidence review

Home page. The home page presents OptionLine as a place to obtain help with an unexpected pregnancy through phone, text, chat, and referral. That sounds supportive, but the limitation is central: the site connects women to a pregnancy-center network that does not provide or refer for abortion services. A public-facing pregnancy resource should make that limitation obvious before a woman enters a counseling pathway.

Pregnancy Overview. This page gives some reasonable basic information. It notes that a missed period does not always mean pregnancy and that testing is needed. The problem is its repeated suggestion that ultrasound is necessary to “confirm” pregnancy. Clinically, a positive urine or serum hCG test confirms biochemical pregnancy. Ultrasound confirms location, gestational age, and viability when indicated.

Early Signs and Symptoms of Pregnancy. This page is mostly accurate in stating that early pregnancy symptoms are nonspecific. Breast tenderness, nausea, fatigue, urinary frequency, and missed menses can occur in pregnancy but can also occur for other reasons. The page appropriately points women toward pregnancy testing. Its weakness is that it funnels users into the same non-neutral service pathway.

Pregnancy Tests. The pregnancy-test page correctly explains that home urine pregnancy tests are most reliable after a missed period and may be falsely negative if taken too early. However, it again overstates ultrasound as the only way to confirm pregnancy. That is not medically precise. The more accurate statement is that ultrasound may be needed to confirm intrauterine location and viability.

“I Don’t Know What to Do.” This page frames abortion, adoption, and parenting as options, which is appropriate in principle. The problem is tone. Abortion is described as “the most immediately permanent” option, which is morally weighted language. Continuing pregnancy, giving birth, parenting, and adoption also have permanent consequences. Balanced counseling should describe all options with the same ethical and emotional neutrality.

Considering Abortion. This page advises women to confirm pregnancy and consider gestational age and viability before abortion. Those points are not wrong. The ethical problem is that the page discusses abortion while routing women to centers that do not provide or refer for abortion. That creates a mismatch between what the user may think she is receiving and what the service actually offers.

Medication Abortion. The medication abortion page identifies mifepristone and misoprostol, but the language is not clinically neutral. It uses terms such as “chemical abortion” and frames progesterone reduction in a way that can sound alarming rather than explanatory. It also implies that ultrasound is generally needed before medication abortion, although evidence-based protocols do not always require ultrasound when dating and ectopic risk can be assessed clinically.¹

Surgical Abortion. This page describes aspiration and dilation procedures, but the wording emphasizes fetal removal and retained “fetal body parts.” That language is not typical patient-centered medical counseling for early aspiration abortion. The page does not give a balanced comparison of procedural safety, gestational age, complication rates, or the risks of delaying care.

Abortion Cost. This page correctly states that abortion cost varies by gestational age, location, procedure type, anesthesia, and other factors. But it is incomplete. It does not sufficiently explain that delay itself can increase cost and reduce available options. Referral to non-abortion-providing centers may therefore have practical consequences for women seeking timely care.

Abortion Safety Checklist. The checklist encourages women to ask about clinician qualifications, emergency planning, and follow-up. Those are reasonable questions. The weakness is asymmetry.

The page raises concerns about abortion safety but does not equally address the risks of continuing pregnancy, the risks of childbirth, or the clinical consequences of delayed abortion access.

After Abortion Support. This page is more balanced than some others because it recognizes that women may feel relief, sadness, regret, or mixed emotions after abortion. That reflects real clinical variation. However, any implication that abortion commonly causes delayed long-term psychological harm should be treated carefully. The evidence does not support abortion as a general independent cause of long-term mental health harm.⁴

Considering Adoption. The adoption page explains open, semi-open, and closed adoption in accessible language. That is useful. But it is incomplete as counseling. Adoption involves grief, legal finality, power imbalance, agency incentives, and potential coercion. A woman considering adoption should have access to independent counseling, not only support from organizations with a preferred pregnancy-continuation framework.

Considering Parenting. The parenting page offers support and encourages women to think about family, finances, and practical needs. That is appropriate. But the discussion is too limited. Parenting decisions must also address medical risk, housing, insurance, intimate partner violence, mental health, childcare, employment, and access to obstetric care. Supportive language is not enough.

“Am I Ready to Have a Baby?” This page offers reflective questions about readiness for parenting. That can be helpful for some women. The concern is not the questions themselves. The concern is where the questions lead. If the pathway leads to a network that does not refer for abortion, that limitation should be stated clearly before the user engages.

Morning-After Pill / Emergency Contraception. This is one of the weakest pages scientifically. The site suggests that emergency contraception may prevent implantation or act as an abortifacient. For levonorgestrel emergency contraception, the best evidence supports a primary mechanism of delaying or inhibiting ovulation, without good evidence of a clinically meaningful post-ovulatory anti-implantation effect.² ³

STDs and STIs. The STI pages appear to offer general sexual-health information. The evidence standard here should be straightforward: recommend testing, condom use, partner notification and treatment when appropriate, and referral for medical care. STI education should not be used mainly as an entry point into pregnancy-center counseling. It should direct users clearly to qualified testing and treatment.

Get Help / Find a Center. The help and referral pages are the practical endpoint of the site. They route women to local centers, phone support, text support, and chat. This is where transparency is most important. Before any personal information is shared, the user should be told plainly that the referred centers provide peer counseling and support but do not provide or refer for abortion services.

Bottom line. Taken page by page, the site contains some accurate basic pregnancy information, but its abortion and emergency contraception content is selectively framed and not consistently evidence-based. Its central ethical problem is not simply that it opposes abortion referral. Organizations may hold that position. The problem is that a pregnancy-options website, especially one appearing in a public resource ecosystem, should disclose that position prominently and should not present non-neutral counseling as neutral medical guidance.

References

1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins. Medication abortion up to 70 days of gestation: ACOG Practice Bulletin No. 225. Obstet Gynecol. 2020;136(4):e31-e47. doi:10.1097/AOG.0000000000004082. PMID:32804884.

2. Endler M, Li R, Gemzell Danielsson K. Effect of levonorgestrel emergency contraception on implantation and fertility: a review. Contraception. 2022;109:8-18. doi:10.1016/j.contraception.2022.01.006. PMID:35081389.

3. Gemzell-Danielsson K, Berger C, Lalitkumar PGL. Emergency contraception: mechanisms of action. Contraception. 2013;87(3):300-308. doi:10.1016/j.contraception.2012.08.021. PMID:23114735.

4. Horvath S, Schreiber CA. Unintended pregnancy, induced abortion, and mental health. Curr Psychiatry Rep. 2017;19(11):77. doi:10.1007/s11920-017-0832-4. PMID:28905259.

Summary

A 33-week pregnant woman posted to r/pregnant after an unplanned hospital visit. She had spotting and silent contractions. The doctors gave her water and a snack. Everything stopped. She was sent home fine. Her post -- written in all caps -- went viral within hours: 493 upvotes, 111 comments. The message was simple: she thought she was hydrated because she was urinating frequently. She was wrong. Frequent urination in pregnancy is caused by fetal pressure on the bladder, not by adequate fluid intake. The two are not the same. Her uterus was cramping from dehydration. The thread quickly filled with identical stories: women at 21, 28, and 35 weeks who had gone to labor and delivery for the same reason and were sent home with water.

Evidence-Based Commentary

Dehydration-triggered uterine contractions are not folklore. The mechanism is physiologically real. Myometrial smooth muscle, like all muscle, is sensitive to electrolyte balance and intravascular volume. Dehydration raises plasma osmolality, triggers antidiuretic hormone (ADH) release, and -- crucially -- stimulates oxytocin co-secretion from the posterior pituitary. Oxytocin drives uterine contractions. This is not a controversial pathway. It is well documented.

The misconception at the center of this post -- that frequent urination equals adequate hydration -- is one of the most common errors I hear from pregnant patients. It needs to be corrected at every prenatal visit. In pregnancy, urinary frequency is driven primarily by the growing uterus compressing the bladder, reducing its functional capacity. A woman can void every 45 minutes and still be volume-depleted if her fluid intake is insufficient. Urine color is a better -- though imperfect -- clinical proxy: pale yellow suggests adequate hydration; dark yellow or amber signals the opposite. One commenter in the thread noticed her urine looked like apple juice at the time of delivery despite hourly voiding. That is not an edge case. That is a predictable consequence of confusing frequency with volume.

How much fluid does a pregnant woman actually need? The honest answer is: it depends, and the guidance in this thread ranged from 100 to 150 ounces per day. ACOG does not issue a specific numeric daily fluid target for uncomplicated pregnancy. The Institute of Medicine (now the National Academy of Medicine) recommends approximately 2.3 liters (roughly 78 ounces) of total water per day from all sources, with higher needs in hot climates, with physical activity, or in the setting of vomiting. A midwife recommending 150 ounces daily is operating well outside evidence-based guidelines -- and for a patient with cardiac or renal compromise, that level of intake could be genuinely dangerous. Blanket high-number targets are not evidence-based. Context matters.

One commenter stated plainly that plain water causes dehydration and that electrolytes must always accompany fluid intake. This is wrong. Electrolyte supplementation is beneficial in specific clinical settings: hyperemesis gravidarum, excessive sweating, or prolonged exertion in heat. For a healthy pregnant woman sitting at home, plain water is appropriate hydration. Overuse of electrolyte packets -- particularly high-sodium formulations -- can contribute to edema and, in susceptible patients, worsen hypertensive disorders. The endorsement of commercial electrolyte products as routine pregnancy supplements, driven partly by influencer marketing, is not supported by evidence.

The thread also surfaced a real clinical challenge: first-trimester nausea that makes adequate fluid intake genuinely difficult. The community’s responses here were largely practical and reasonable -- popsicles, diluted juice, small frequent sips, Pedialyte. From a clinical standpoint, the key threshold is this: if a patient cannot keep any fluids down for more than 24 hours, or if she shows signs of ketonuria, orthostatic hypotension, or weight loss, she needs IV hydration and evaluation for hyperemesis gravidarum -- not Reddit advice. The community is rightly encouraging each other to drink; the limits of that encouragement are what providers need to establish clearly.

What It Means

This thread represents a real and preventable gap in prenatal education. Women are reaching 33 weeks of pregnancy -- past viability, well into the third trimester -- without understanding that frequent urination does not mean adequate hydration. That is a failure of prenatal counseling, not a failure of the patient. The information she needed was simple, practical, and potentially saved her from a much more complicated outcome. If this woman had been farther from a hospital, if she had dismissed the spotting, if the contractions had continued -- the stakes escalate quickly.

Obstetric providers should address hydration directly at every visit in the third trimester: not a pamphlet, not a general reminder, but a specific conversation about urine color as a monitoring tool, the inadequacy of urinary frequency as a hydration proxy, and individualized fluid targets based on the patient’s size, activity level, climate, and clinical picture.

Subscribe now

My Take

I have watched this happen on labor and delivery more times than I can count. A patient arrives with contractions she cannot feel, a fetal heart rate that looks fine, and a urine sample that tells the whole story. We give her two liters of IV saline. The contractions stop. She goes home. The visit should never have happened.

What strikes me about this thread is not the original post -- that story is familiar. What strikes me is the noise. Women are getting conflicting fluid targets from their providers: 100 ounces from one OB, 150 from a midwife, 120 from the internet. Nobody is explaining why. Nobody is giving them a tool they can use at home -- like urine color -- to actually monitor themselves. Instead, they are collecting numbers and doing the math wrong.

And underneath all of it: a perfectly correctable misconception. Frequent urination does not mean you are hydrated. In pregnancy, it means you have a baby sitting on your bladder. Every prenatal provider should say that sentence out loud, at every third-trimester visit, until it sticks. It takes ten seconds. It might prevent a hospital admission.

I decided to find out.

I took two real clinical scenarios and asked them across three tiers of Claude:

Free, Pro, and Max.

What I found is not a sales pitch. It is a clinical observation. And like most clinical observations, the data matter more than the opinion.

Subscribe now

What are the tiers?

Claude is the AI made by Anthropic. It comes in several models, and the model you access depends on what you pay. The free tier uses Haiku, Anthropic’s fastest and lightest model. It is designed for quick answers and short tasks. Pro, at $20 per month, gives you Sonnet, a meaningfully more capable model, with five times more usage than the free plan. Max, at $100 or $200 per month, gives you Opus, Anthropic’s most powerful model, with priority access and the highest usage limits.

Think of it like hospital staffing. Free is the intern who has read the textbook. Pro is the senior resident who has also seen the cases. Max is the attending who has seen the cases, read the trials, and is about to tell you exactly why the textbook got it wrong.

For most tasks, free Claude is fine. For clinical reasoning under uncertainty, the tiers are not interchangeable. Here is the evidence.

Share

The scenarios

I chose two cases that most obstetric clinicians encounter: a preeclamptic patient at 29 weeks, and a patient with a prior spontaneous preterm birth at 27 weeks presenting at 18 weeks with a 15-millimeter cervix. Neither is a trick question. Both require real clinical judgment.

I asked each version of Claude: manage this patient, briefly. Then I read what came back.

What Free Claude said

Scenario 1: Severe preeclampsia at 29 weeks

Admit, monitor BP and labs. IV magnesium sulfate for seizure prophylaxis. Antihypertensives if BP is 160 over 110 or higher. Betamethasone for fetal lung maturity. Deliver if maternal or fetal status deteriorates.

Scenario 2: History of preterm birth at 27 weeks, now 18 weeks with cervical length 15 mm

High risk for recurrent preterm birth. Start vaginal progesterone. Consider cerclage given short cervix. Serial cervical length monitoring. Discuss signs of preterm labor. Refer to MFM.

Both answers are correct. Neither is wrong. If you posted either one on a medical board review forum, no one would mark it incorrect. But correct and complete are not the same thing. Free Claude gives you a checklist. It does not give you a clinical argument. It does not tell you why, when, or with what evidence. It does not tell you the 15-millimeter cervix plus prior 27-week birth is not just a risk factor but a dual indication that puts a cerclage placement window in front of you right now.

For a nurse triaging at intake, free Claude is useful. For clinical decision-making at the bedside, it is the floor, not the ceiling.

Subscribe to ObGyn Intelligence to read the Pro and Max responses, and to understand exactly what you are paying for — and whether it matters clinically.

Below, paid subscribers will find the Pro and Max responses to both scenarios, and my analysis of what distinguishes each tier clinically.

Read more

A woman dies from a pregnancy-related infection in the United States. Her family grieves. A report is filed. A committee meets. The word “preventable” appears in the documentation.

And next year, another woman dies.

A study published in Obstetrics and Gynecology analyzed data from Maternal Mortality Review Committees in 29 states covering pregnancy-related deaths from infection between 2017 and 2019. Of the 88 deaths fully assessed, 86.4% were determined to be preventable. Not possibly preventable. Preventable with existing knowledge and available interventions.(1)

The review catalogued 27 contributing factor classes.

The five most common accounted for 56.2% of all factors identified: clinical skill and quality of care (18.6%), delays (10.1%), knowledge (10.1%), lack of continuity of care (9.6%), and lack of access or financial resources (7.8%).(1) This post addresses each one directly, including where hospitals and ACOG have failed, and where AI can do what human systems have not.

1. Clinical Skill and Quality of Care (18.6%)

This was the single most frequently cited contributor. Nearly 1 in 5 contributing factors pointed to deficiencies in clinical skill or the quality of care delivered. In the context of infection, this means failure to recognize sepsis early, failure to apply evidence-based obstetric sepsis protocols, and failure to escalate care when early warning signs appeared. Maternal sepsis is treatable. Bundle-based care, including early antibiotics, fluid resuscitation, and source control, reduces mortality. The problem is not the absence of a protocol. The problem is inconsistent application of protocols that already exist.

Where hospitals and ACOG have failed:

Hospitals have known for years that sepsis bundles save lives. The Surviving Sepsis Campaign published obstetric adaptations over a decade ago. Yet implementation remains uneven, driven by no mandatory accreditation standard requiring obstetric-specific sepsis protocols. ACOG has issued guidance documents but has stopped well short of mandating protocol adoption or linking quality metrics to credentialing. A guideline that a hospital can ignore without consequence is not a standard of care. It is a suggestion. When 18.6% of maternal infection deaths trace back to clinical skill and quality failures, suggestions are not enough.

AI solution:

AI-powered clinical decision support tools can monitor patient vitals in real time and flag sepsis criteria before a human clinician recognizes the pattern. Systems trained on obstetric-specific parameters, including the modified early obstetric warning score, can alert nurses and physicians when a postpartum patient meets threshold criteria, regardless of how busy the unit is or how experienced the covering clinician. An AI that never gets tired and never overlooks a trending heart rate is not a replacement for clinical judgment. It is a backstop against the lapses that review committees keep documenting. This technology exists today. The barrier is deployment, not invention.

2. Delays (10.1%)

The “three delays” framework has been used in global maternal health for decades: delay in seeking care, delay in reaching care, delay in receiving care once at the facility. In the United States, the third delay, receiving care once inside the hospital, remains a documented killer. The Joseph et al. analysis noted that delays in antibiotic administration were common across reviewed deaths.(1) Antibiotics for sepsis are time-sensitive. Every hour of delay increases mortality. Delays happen for predictable and addressable reasons: understaffed emergency departments, triage systems that do not flag postpartum patients appropriately, and clinicians who do not recognize obstetric warning signs outside a labor and delivery setting.

Where hospitals and ACOG have failed:

Most hospital triage protocols were not designed with postpartum patients in mind. A woman presenting to an emergency department nine days after delivery is often triaged the same way as any adult with a fever, without the obstetric-specific escalation her condition demands. ACOG has not established a national standard requiring hospitals to implement postpartum-specific triage pathways in emergency departments. Without that standard, individual hospitals set their own protocols or none at all. The result is that the speed of care a postpartum woman receives in an emergency room depends largely on whether the triage nurse happens to know that the obstetric rules are different.

AI solution:

AI triage tools can identify postpartum status from registration data and immediately flag the patient for obstetric-specific assessment criteria. A patient who enters her recent delivery date at check-in should trigger an automated alert that modifies her triage pathway before she is ever seen by a nurse. Natural language processing tools can also scan electronic health record notes in real time, identifying language that suggests a clinician is not applying urgency appropriate to the presentation, and prompt a secondary review. Time-to-antibiotic is a measurable outcome. AI systems can track it continuously across an entire hospital system and surface outliers before the next death, not after.

3. Knowledge (10.1%)

Knowledge gaps contributed to roughly 1 in 10 identified factors. Some gaps were on the patient side: a woman who does not know that fever and rapid heart rate three days after delivery are warning signs cannot seek care she does not know she needs. But knowledge gaps also exist on the clinician side. The MMRCs found that clinicians in emergency department and outpatient settings need education on modified obstetric early warning signs.(1) A clinician who sees a postpartum patient in an urgent care clinic and does not apply obstetric-specific criteria is a knowledge gap at the system level.

Where hospitals and ACOG have failed:

ACOG publishes educational materials. It runs continuing medical education programs. But there is no mechanism ensuring that the emergency physician who sees a postpartum woman at day 10 has ever received training on obstetric sepsis recognition. Cross-departmental education, reaching emergency medicine, internal medicine, and urgent care, is not systematically required. Discharge instructions given to postpartum women vary by hospital, by clinician, and by shift. There is no federal or professional society standard mandating that every woman discharged after delivery receives written, plain-language information about infection warning signs and a clear instruction about when and where to seek care. That is a knowledge delivery failure at the institutional level.

AI solution:

AI can close the knowledge gap on both sides simultaneously. For patients, AI-powered postpartum apps can deliver daily check-ins after discharge, ask about symptoms, and trigger escalation pathways when warning signs are reported. The technology to build this exists and is not expensive. For clinicians, AI decision support tools can embed obstetric-specific guidance into the emergency medicine and urgent care workflow, surfacing postpartum sepsis criteria automatically when a patient’s recent delivery is noted in the chart. An AI that knows what a human clinician was never formally taught is not a workaround. It is what the system should have provided in the first place.

[PAYWALL BREAK]

4. Lack of Continuity of Care (9.6%)

Nearly 1 in 10 contributing factors involved a breakdown in continuity. A woman delivers at a hospital. She is discharged at 48 to 72 hours. Her next scheduled appointment is at six weeks. In between, she is alone with a newborn, healing from either a vaginal delivery or major abdominal surgery, navigating a body undergoing the most rapid physiologic change of her adult life. If she develops an infection at day five, there is no standard system designed to catch her. She may call her obstetrician’s office and be told to wait and see. She may go to an urgent care that cannot recognize postpartum sepsis. The failure is not any individual clinician’s wrong decision. The failure is that no connected system was designed to prevent that situation.

Where hospitals and ACOG have failed:

The six-week postpartum visit was the standard of care for generations despite no evidence that six weeks is the right interval for detecting postpartum complications. ACOG updated its guidance in 2018 to recommend earlier contact, ideally within three weeks, and a comprehensive visit by 12 weeks. That update was an improvement. It was not a solution. “Contact” can mean a phone call. It does not ensure that a woman with early infection signs is identified or that her care is coordinated across the obstetric, emergency, and primary care systems she may touch in the weeks after delivery. Hospitals have not built the infrastructure this coordination requires, and ACOG has not made that infrastructure a condition of quality.

AI solution:

AI-powered remote monitoring platforms can maintain active contact with postpartum women from the day of discharge through the first six weeks. Automated symptom check-ins by text, app, or voice can identify warning signs daily rather than waiting for a scheduled visit. When a woman reports fever, increasing pain, or malaise, an AI system can escalate immediately to a human clinician for follow-up, routing her to the appropriate level of care within minutes rather than days. This is not futuristic. Postpartum remote monitoring programs using these tools have already been piloted. The evidence supports their utility. What is missing is the institutional commitment to deploy them at scale and the professional society standard that would make them the expectation rather than the exception.

5. Lack of Access or Financial Resources (7.8%)

Access and financial barriers were cited in nearly 1 in 12 contributing factors. This is likely an undercount. Women who cannot access care are not always captured in committee reviews the same way deaths inside the health system are. But the deeper story here is not just about insurance gaps. It is about what happens when Medicaid pays obstetricians and hospitals at rates that are 30 to 50 percent below commercial insurance rates. Physicians and hospitals respond to that gap the same way any business responds to below-cost reimbursement: they limit exposure. The result is that the 40% or more of pregnant women in the United States who are on Medicaid, disproportionately Black, Hispanic, and rural women, face a two-tiered system in which their coverage exists on paper and their access exists in theory.

Where hospitals and ACOG have failed:

ACOG has advocated for Medicaid expansion and for extending postpartum coverage to 12 months. That advocacy is on the record and is appropriate.

What ACOG has not done is confront the reimbursement discrimination that makes Medicaid a second-class card in a first-class system. When obstetricians limit the number of Medicaid patients they will see, when hospitals close obstetric units in low-income communities because the margin does not pencil out, the professional society responsible for the standard of care has an obligation to say that this is not acceptable. It has not said that with the force the situation demands.

Universal healthcare coverage, or at minimum Medicaid reimbursement parity with commercial rates, is not a political position. It is a precondition for the word “preventable” to mean anything at all.

AI solution:

AI cannot fix a reimbursement structure that devalues the lives of low-income women. But it can reduce the cost of delivering care to underserved populations enough to change the math. AI-powered telehealth platforms dramatically lower the overhead of postpartum follow-up visits, making it economically feasible to see Medicaid patients at higher frequency without the facility costs of in-person care. AI tools that automate Medicaid enrollment verification, coverage extension applications, and connection to community health workers can reduce the administrative burden that drives clinicians away from Medicaid panels. The goal is to make caring for Medicaid patients less costly to deliver until the payment system catches up to what equity requires. That is a bridge strategy, not a solution. The solution is parity.

My Take

These five contributors, and the data behind them, are not a surprise to anyone who has followed maternal mortality review committee findings over the past decade. What they reveal is not a mystery. They reveal a system that has identified its failures in precise detail and has not restructured itself to fix them.

86.4% of pregnancy-related infection deaths are preventable. That figure should be on the wall of every labor and delivery unit in the country. It should drive quarterly quality reviews, accreditation standards, and professional accountability. It should inform how we train emergency physicians, how we design discharge instructions, how we structure postpartum follow-up, and how we deploy technology.

The AI solutions I have described are not hypothetical. The tools exist. Remote monitoring platforms, AI-powered triage alerts, clinical decision support for sepsis recognition, discharge risk screening, postpartum symptom apps: each of these is deployable today. What they require is the institutional will to deploy them and the professional society leadership to make them the standard rather than the experiment.

ACOG issues guidelines. Hospitals implement selectively. Women die preventably. That cycle has continued long enough. AI will not replace clinical skill, eliminate financial barriers by itself, or fix a broken triage system through algorithm alone. But AI can close the gaps that human systems, through inertia, underfunding, and inconsistent accountability, have refused to close themselves.

Patients are not passive in this. Ask your hospital what postpartum monitoring they provide between discharge and your first appointment. Ask whether your discharge instructions include specific infection warning signs. Ask whether your coverage continues after delivery. The answers will tell you more about your safety than any brochure.

Bottom Line

Eight in ten pregnancy-related infection deaths are preventable. Review committees in 29 states documented why they keep happening: clinical skill failures, treatment delays, knowledge gaps, disconnected postpartum care, and financial barriers that block access before infection can be treated. Hospitals have known these failure points for years. ACOG has documented them and stopped short of mandating the fixes. AI-powered tools, deployed at discharge, in triage, in remote monitoring, and in clinical decision support, can do what the current system has failed to do. The technology is ready. The question is whether the institutions responsible for women’s lives are ready to use it.

References

1. Joseph NT, Trost SL, Hollier LM, Perkins KM, Goodman DA, Leonard M, Busacker A. Pregnancy-related mortality due to infection: maternal mortality review committees in 29 U.S. states, 2017-2019. Obstet Gynecol. 2026. doi:10.1097/AOG.0000000000006172

2. Hoyert DL. Maternal mortality rates in the United States, 2024. NCHS Health E-Stats. 2026. Available from: https://www.cdc.gov/nchs/data/hestat/hestat113.htm

3. Hoyert DL. Maternal mortality rates in the United States, 2023. NCHS Health E-Stats. 2025. doi:10.15620/cdc/170564

Amos Grunebaum, MD | ObGyn Intelligence - Evidence Matters | obmd.com

Stylized image of hantavirus

Last week, while the MV Hondius was somewhere between St. Helena and Ascension Island, a 70-year-old Dutch passenger developed fever, headache, abdominal pain, and diarrhea. He died before reaching shore. His 69-year-old wife became ill on board and collapsed at O.R. Tambo International Airport in Johannesburg. She died there. A third passenger, a British national, tested positive for hantavirus. Three dead, six infected, one ship, one unusual pathogen.

The WHO is coordinating a multi-country response. The ship’s operator, Oceanwide Expeditions, has acknowledged the deaths while noting that hantavirus has not been definitively linked to all three. The investigation is ongoing.

Hantavirus is carried by rodents. It spreads when people inhale particles from dried droppings or urine. The Andes virus, found in South America, is the only strain known to spread person-to-person. The CDC has recorded 890 U.S. cases since surveillance began in 1993. This is not a common infection. Six cases on one ship is, in the words of a University of Michigan infectious disease specialist, something she had never heard of before.

I am not an infectious disease specialist. I am an obstetrician. But when I read this story, my first thought was not epidemiological. It was clinical.

My pregnant patients go on cruises. They travel to South America, sub-Saharan Africa, Southeast Asia. They clean mouse traps in their garage. They live in houses, not isolation chambers. And they carry a passenger whose immune relationship with the world has been fundamentally altered by pregnancy.

Pregnancy is not immunosuppression in the classical sense. It is immune modulation. The body performs a sophisticated tolerance trick to prevent rejection of a genetically foreign fetus, and that trick has consequences. Viral infections that cause mild illness in a non-pregnant adult can cause preterm labor, fetal loss, congenital anomalies, or maternal death in a pregnant patient. The virus does not change. The host does.

This is not a story about hantavirus specifically. It is a story about the full landscape of viruses that matter in obstetric care, and whether we are thinking about all of them every time we take a history, counsel a traveler, review immunization status, or manage a febrile patient in labor.

The answer, in my experience, is often no.

We are excellent at HIV. We screen universally, and our protocols for antiretroviral therapy and delivery management have reduced vertical transmission to under 1% in managed settings. We are good at hepatitis B because newborn immunization protocols and HBIG administration are embedded in delivery room practice. We think about HSV near term. We worry about varicella in the non-immune patient.

We are less systematic about the rest of the list.

CMV is the most common congenital infection in the world. It causes more permanent hearing loss and cognitive impairment in children than any other infectious agent. We do not screen for it universally in pregnancy. Most patients have never heard of it. Most of the public conversations about birth defects do not mention it. We counsel patients about cat litter and Listeria but not about the daycare worker sharing a cup of juice with a toddler who is shedding CMV in her saliva.

Parvovirus B19 causes hydrops fetalis. It is not rare. It circulates in schools and daycares. A school teacher or childcare provider who becomes infected in the second trimester faces the real possibility of fetal anemia severe enough to require intrauterine transfusion. The recognition window is narrow and the clinical picture in the mother is often unremarkable.

Zika is not gone. It is quieter. But the Aedes mosquito has not retired, and our patients still travel to endemic regions. Congenital Zika syndrome is one of the most devastating congenital infections documented in the modern era: microcephaly, cortical malformations, hearing loss, ocular defects. The counseling burden for a patient with a potential exposure and an ongoing pregnancy is substantial, and the evidence base for timing, testing, and surveillance is still not what it should be.

Hepatitis E deserves more attention in obstetric practice than it receives. In endemic regions, the case fatality rate for pregnant patients in the third trimester can exceed 25%. This is not a footnote in an ID textbook. It is a reason to take a careful travel and dietary history in every pregnant patient who presents with jaundice or hepatic dysfunction.

I have put together the table below as a working clinical reference. It is not exhaustive, and it is not a substitute for infectious disease consultation when you need one. But it is the list I wish I had seen as a resident. Every virus on it has documented maternal, fetal, or neonatal consequences. Every one of them has a potential interaction with pregnancy that changes management.

The table organizes them by category, summarizes the relevant maternal and fetal risks, and notes transmission routes and prevention strategies. I have included vaccines and interventions only where they are evidence-based, approved for use, or specifically recommended in or around pregnancy. I have not filled gaps with optimism.

A few observations from this table.

First, the vaccine column is shorter than it should be. We have effective vaccines against influenza, COVID-19, RSV, hepatitis A, hepatitis B, rubella, measles, mumps, varicella, HPV, polio, and rabies. Several of these are contraindicated during pregnancy (live vaccines) but should be given postpartum before the next conception. Others are specifically recommended in pregnancy. The prenatal visit is an immunization opportunity. We do not always use it as one.

Second, vertical transmission risk varies enormously within the table. For HIV without intervention, vertical transmission is 15 to 45 percent. For hepatitis B with HBeAg positivity and no prophylaxis, it approaches 90 percent. For CMV primary infection in the first trimester, the risk of congenital infection is approximately 30 to 40 percent, with a subset developing symptomatic disease. For rubella in the first trimester, the risk of congenital rubella syndrome exceeds 80 percent. These are not small numbers.

Third, the table contains several viruses that most practicing obstetricians will never encounter in clinical practice in the United States. LCMV, Lassa fever, Ebola. But global travel has made the world smaller. A patient who spent three weeks in West Africa visiting family, or who was on a cruise ship that stopped in South America, is a patient who belongs in front of an obstetrician with a complete viral differential. The geography of risk has changed. The training has not always kept pace.

The hantavirus cluster on the MV Hondius was unusual. But it reminded me of something that does not require a cruise ship or a rare outbreak to be true: the pregnant patient is a uniquely vulnerable host, and the viruses that threaten her are not limited to the ones on the standard prenatal panel.

My Take

The prenatal visit is one of the most intensive scheduled contacts between a patient and the healthcare system. We draw blood, check blood pressure, measure fundal height, review medications. We do not routinely ask about rodents.

That is not a criticism. You cannot ask about everything. But the viral risk landscape in pregnancy is broad, and the standard first prenatal visit template does not capture most of it. Travel history, occupational exposures, household contacts, immunization history, sexual history — these are the vectors that bring most of these viruses into the obstetric encounter. A teacher in a classroom full of young children is in a different CMV and parvovirus risk category than a remote worker who leaves the house twice a week. A patient who just returned from a Zika-endemic country is in a different conversation than one who spent her vacation in Maine.

We collect the information we are trained to collect. This table is an argument for expanding the frame.

The pregnant patient does not exist inside an infectious disease specialty line. Viruses do not check credentials at the door. The obstetrician who sees a febrile patient in the third trimester should be comfortable thinking across this entire table, not just the pathogens covered in a standard infectious disease in pregnancy lecture from 1995.

Three people died on a ship in the Atlantic from something carried by rodents, spread by breath, and diagnosed in a laboratory in South Africa while the vessel was off the coast of Cape Verde. It took a lot of geography to get to a simple conclusion: the world is smaller than our specialty silos.

If this post is useful, forward it to a colleague or a resident. If something on the table is wrong or missing, tell me. I update these references when the evidence changes.

Subscribe to ObGyn Intelligence for evidence-based commentary on women’s health every week — no sponsored content, no wellness industry partnerships, no hedging when the data is clear.

Selected References

1. Petri AE, Albeck-Ripka L. 3 Dead of Suspected Hantavirus Infections on Cruise Ship, W.H.O. Says. New York Times. May 3, 2026.

2. Centers for Disease Control and Prevention. Hantavirus Disease Cases Reported in the United States, by Year Reported, 1993-2023. Atlanta: CDC; 2024.

3. Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol. 2015;73(3):199-213.

4. Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015;125(1):212-226.

5. Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188.

6. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425-433.

7. Brasil P, Pereira JP Jr, Moreira ME, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321-2334.

8. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10(1):61-69.

9. CDC. Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2024. MMWR Recomm Rep. 2024.

10. WHO. Hantavirus Disease — Multi-country Event. Disease Outbreak News. May 4, 2026.

What the Word ‘Bias’ Actually Means

The word bias comes from the Old French biais, meaning a slant, a slope, a diagonal cut across the grain of cloth. Like a floor that is not quite level: everything placed on it rolls the same way, not because anyone pushed it, but because the floor was built wrong.

When a tailor cuts fabric “on the bias”, the cut runs …

Read more

Peter Drucker the business guru never attended a delivery. But he understood institutions better than most people who run them. His warning, issued decades ago, applies to American obstetrics with uncomfortable precision: if you want something new, you have to stop doing something old.

We are not short of new things. New protocols. New screening tools. New committee recommendations. New quality improvement initiatives. What we are short of is the discipline to ask which old things are not working, and the institutional courage to stop them.

The numbers demand that conversation now.

What the Numbers Show

The United States spends more on maternity care than any country in the world. The return on that spending is, by any honest measure, poor.

The U.S. maternal mortality ratio is approximately 23 deaths per 100,000 live births.

The United Kingdom, with its MBRRACE-UK surveillance system and rigorously evidence-anchored NICE guidelines, reports a ratio near 9 per 100,000. (1,2) That is not a rounding error. It is a structural failure.

Subscribe now

These are not mortality rates from the same distribution shifted slightly. They represent different systems producing different outcomes. The U.S. figure has not fallen in decades. The UK figure, while still unacceptably high, reflects a national system that reviews every maternal death, publishes its findings transparently, and asks directly: what should we have done differently?

We have reviewed our outcomes too. The difference is what happens next.

What We Keep Adding

The American response to poor maternal outcomes has been, almost without exception, additive.

More screening.

More documentation.

More checklists.

More bundles. More task forces.

More language in guidelines telling clinicians to “consider” and “offer” and “discuss” interventions whose evidence base ranges from solid to speculative.

And now. More Doulas.

ACOG guidelines, across twelve domains scored in my ongoing GAAP analysis, average 1.96 citations per clinical recommendation and achieve evidence-action ratios of 46 percent, meaning fewer than half of their recommendations are fully matched to the evidence they cite. (3) NICE guidelines average 0.99 citations per recommendation and achieve evidence-action ratios of 68 percent. (3) This is not a criticism of individual physicians or guideline authors. It is an observation about a system that has become comfortable with expansion and uncomfortable with subtraction.

We add smoking cessation counseling to prenatal visits without removing the parts of those visits that have never been shown to improve outcomes.

We add implicit bias training without examining which institutional practices produce the disparities we are trying to address.

We add maternal safety bundles without asking whether the baseline care into which those bundles are inserted is itself optimized.

We now add doulas without evidence that they effect outcomes.

Drucker’s insight was not about innovation. It was about capacity. Every organization has finite attention, finite time, and finite resources. When you add without subtracting, you do not improve the old thing or establish the new one. You dilute both.

What the UK Stopped

The MBRRACE-UK programme, which has surveilled UK maternal deaths continuously since 1952, is not primarily a counting exercise. It is a stopping mechanism. Each triennial report identifies care that was suboptimal, names the patterns, and gives clinicians and institutions the data they need to discontinue practices that are not protecting women. (2)

NICE guidelines, by contrast with ACOG’s, are notable for what they do not include. They do not recommend interventions without adequate evidence. They do not use the phrase “reasonable to offer” as a placeholder for clinical uncertainty. When evidence is insufficient, NICE says so and waits. (4)

Subscribe now

That restraint is itself a policy decision. It reflects the understanding that recommending something you cannot support with evidence does not empower clinicians. It confuses them. And it adds to the pile of things clinicians are expected to do in a visit that already cannot hold everything it is asked to carry.

What Needs to Stop Here

I am not suggesting we dismantle American obstetrics. (Or maybe it’s not such a bad idea?)

I am suggesting we apply Drucker’s test, seriously and systematically, to what we are currently doing.

Which prenatal screening interventions improve outcomes when broadly applied, and which generate anxiety, follow-up visits, and additional cost without changing what happens to the mother or the baby? Which elements of postpartum care protocols are delivered as ritual rather than as evidence-based intervention? Which guideline recommendations are carried forward from one edition to the next because no one has formally asked whether they should be retired?

The discipline of stopping is harder than the discipline of starting. Starting feels like progress. Stopping feels like defeat, or like admitting that something we did for years did not work. In medicine, that admission is especially uncomfortable because it implies that women who did not benefit from those years of practice were owed something different.

They were. Saying so is not a condemnation of the physicians who followed the guidelines. It is the precondition for building something better.

Adding ‘Racism’ Without a Mechanism Is Not an Explanation

Racial disparities in maternal mortality are real, well-documented, and morally unacceptable. Black women in the United States die from pregnancy-related causes at approximately three times the rate of white women. (5) That disparity demands serious investigation and serious response. It does not demand that we accept every proposed explanation as equivalent, or every proposed remedy as effective.

In recent years, “racism” has been added to the list of maternal mortality causes in a way that functions more as a statement of values than as an operational hypothesis. The claim that racism causes maternal death is not wrong as a broad social observation. The problem is that naming it without specifying the mechanism, the point of clinical intervention, or the measurable outcome produces nothing actionable. It adds a category without subtracting confusion.

The relevant questions are specific ones. Does implicit bias in triage decisions delay recognition of hemorrhage? Do communication failures between patients and clinicians reflect power differentials that can be structurally addressed? Are Black women with hypertensive disorders less likely to receive timely antihypertensive therapy, and if so, at what step in the care pathway does that failure occur? (6) These questions have testable answers. Programs built around them can be evaluated. Programs built around the general premise that racism is the cause cannot be, and when they cannot be evaluated, they cannot be stopped when they fail.

The same Drucker test applies here.

Adding “anti-racism training” to an already overcrowded institutional agenda, without a specified mechanism linking that training to a measurable reduction in maternal deaths among Black women, is addition without evidence. It may make institutions feel they are responding. It does not make them respond.

Doulas Are Not a Mortality Intervention

Doulas provide genuine value within the scope of what they are trained to do. Continuous labor support is associated with shorter labors, lower rates of cesarean delivery, and higher patient satisfaction. (7) Women who want a doula and can access one are better served with one than without one. That is a real finding and it should not be dismissed.

But doulas are not trained to recognize hemorrhage. They are not trained to manage hypertensive emergencies. They cannot interpret a deteriorating fetal heart rate tracing, administer magnesium sulfate, place a uterine balloon, or perform a hysterectomy for placenta accreta. These are not gaps that advocacy can close. They are the direct, proximate causes of maternal death in the United States: hemorrhage, hypertensive disorders, sepsis, thromboembolism, and cardiomyopathy. (8)

Positioning doulas as a maternal mortality intervention is a category error.

It confuses emotional and advocacy support, which doulas provide well, with clinical recognition and clinical response, which only trained clinicians can provide. The conditions that kill women require timely diagnosis and timely treatment. A doula can insist that a nurse check on her patient. She cannot do what happens after the nurse arrives.

The countries with much lower mortality rate have no doulas.

The category error reflects poorly on the policymakers making the argument, not on the doulas themselves. Doulas did not ask to be the answer to a 23-per-100,000 mortality rate. They are being handed that responsibility by legislators and advocates who find it easier to fund a new support role than to fix the clinical system failures that are actually killing women. Expanding Medicaid coverage for doulas is a political achievement. It is not a mortality intervention. Calling it one misrepresents the evidence, misdirects resources, and, when the mortality numbers fail to move, produces the false conclusion that we tried and the problem is intractable.

The problem is not intractable. The interventions that reduce maternal mortality are known: standardized hemorrhage protocols, timely antihypertensive treatment, early warning systems, mandatory case review. These require institutional commitment and clinical accountability. They do not have a constituency as warm and sympathetic as doulas. That is a political fact, not an evidentiary one, and we should not let it determine where the resources go.

My Take

The U.S. maternal mortality rate will not improve through addition alone. We have been adding for decades. The gap between our outcomes and those of comparable countries has not closed. It has, in some analyses, widened.

What we need is an honest inventory: what are we doing, what does the evidence say about each of those things, and what should we stop. That is not a political position. It is a clinical one. Drucker understood it as a management principle. MBRRACE understands it as a surveillance imperative. We should understand it as a professional obligation.

Racial disparities in maternal mortality are a genuine emergency. They deserve interventions proportional to that emergency: specific, mechanistic, measurable, and willing to be evaluated. Naming racism without specifying a clinical pathway is not that. Funding doulas without evidence they reduce mortality is not that. Both can coexist with the harder work of fixing the clinical system failures that are actually killing women, but only if we are honest about what each intervention can and cannot do.

The word “consent” does not appear in a single one of the twelve ACOG guidelines I have scored in this series. That is not a minor omission. It is a signal about whose interests those guidelines are organized around. Stopping the practices that prioritize institutional comfort over patient outcomes is exactly where this inventory should begin.

If you find this analysis useful, consider subscribing to ObGyn Intelligence. Evidence matters. So does acting on it.

References

1. Hoyert DL. Maternal mortality rates in the United States, 2021. NCHS Health E-Stats. 2023. [VERIFY: confirm most recent NCHS data year and rate]

2. Knight M, Bunch K, Patel R, et al. MBRRACE-UK: Saving Lives, Improving Mothers’ Care. National Perinatal Epidemiology Unit, University of Oxford; 2023. [VERIFY: confirm most recent MBRRACE triennial report citation]

3. Grunebaum A. GAAP series: Guideline Accountability and Action-to-Evidence analysis, Posts 1-11. ObGyn Intelligence, obmd.com. 2024-2025.

4. National Institute for Health and Care Excellence. Evidence standards framework for digital health technologies. NICE; 2022. [VERIFY: confirm specific NICE methodology document for guideline restraint]

5. Hoyert DL, Miniño AM. Maternal mortality in the United States: changes in coding, publication, and data release. Natl Vital Stat Rep. 2020;69(2):1-18. [VERIFY: confirm most current race-stratified maternal mortality data citation]

6. Shields LE, Wiesner S, Klein C, Pelletreau B, Hedriana HL. Use of maternal early warning trigger tool reduces maternal morbidity. Am J Obstet Gynecol. 2016;214(4):527.e1-6. [VERIFY: confirm best available citation for race-based disparities in triage/treatment delay]

7. Bohren MA, Hofmeyr GJ, Sakala C, Fukuzawa RK, Cuthbert A. Continuous support for women during childbirth. Cochrane Database Syst Rev. 2017;7:CD003766. [VERIFY: confirm most recent Cochrane update on continuous labor support]

8. CDC Division of Reproductive Health. Pregnancy mortality surveillance system: causes of pregnancy-related deaths. Atlanta: CDC; 2023. [VERIFY: confirm most recent PMSS data on leading causes]

They are right about that.

They also blur the line between coverage, access, and quality, and they cannot decide whether race is a social construct or an analytic category.

Two papers landed in the same issue of Obstetrics & Gynecology, both arguing that policy and structure drive severe maternal morbidity.

One is a Medicaid claims analysis of nearly seven million deliveries (1). The other is a clinical perspective on inequalities in high-income countries (2).

Read together, they are presented as a coherent case for expanding insurance, addressing structural racism, and reorganizing health systems around equity. Read carefully, they reveal a set of unresolved contradictions that the authors do not name and most readers will not catch.

The underlying question is serious.

American women are dying at rates that the rest of the high-income world does not tolerate, and the burden falls hardest on the women with the least power to push back. I support universal coverage. I support structural action on the social determinants of health. The criticism that follows is not aimed at those goals. It is aimed at the looseness with which these two papers conflate coverage, access, and quality, and the way the inequalities paper builds an argument on racial categories it has just told us are not real.

The Race Problem the Authors Create and Then Ignore

Vousden and colleagues open with a definition. Race is “a group of people connected by common descent or origin.” Ethnicity is “membership of a group, ultimately of common descent or having common national or cultural tradition.” Inequalities, they write, are “neither natural nor biologically determined.” Race, in other words, is a social category without biological grounding.

And then for the rest of the paper, they categorize, count, stratify, and report by race. Go figure.

Black women in the UK have a 2.3 times higher risk of maternal death than White women. Black women in the US have three to four times the risk. Black African and Bangladeshi women in the UK have the highest rates of severe maternal morbidity.

These numbers appear throughout the paper as if the categories doing the counting are stable, meaningful, and comparable across the Atlantic. They are not.

“Black” in the United States is not the same population as “Black” in the United Kingdom, which is not the same population as “Black African” in France.

“Hispanic” in a US dataset includes women whose ancestors arrived 400 years ago and women who arrived last week, from twenty different countries with very different health profiles.

The paper itself acknowledges this when it points out that migrant women from sub-Saharan Africa, the Caribbean, and parts of Asia carry higher risk than other migrants.

That is the right observation. It also undermines the racial categories the rest of the paper depends on.

The authors cannot have it both ways.

Either race is a coherent enough category to drive a paper full of disparity statistics, or it is so socially constructed and context-dependent that the disparity statistics need a different framing. The honest position is the second one. The paper does not take it.

This matters at the bedside. When a woman walks into Labor and Delivery, what we want to know is her actual risk profile, which includes obesity, hypertension, prior pregnancy outcomes, access to prenatal care, language barriers, housing stability, and trust in the health system. Race is a crude proxy for some of these and an irrelevant proxy for others. Treating it as a unified risk factor produces both undertreatment when a White woman with the same social vulnerabilities is missed, and overgeneralization when a Black woman with abundant resources is treated as high-risk on category alone.

What the Medicaid Paper Actually Shows

Guernsey and colleagues report that in 30 states that expanded Medicaid under the Affordable Care Act, women who delivered at least 21 months after expansion had lower odds of severe maternal morbidity than women who delivered before expansion (odds ratio 0.79, 95 percent CI 0.68 to 0.90 with transfusion, 0.76, 0.65 to 0.88 without) (1). The absolute risk reduction was 0.5 percent with transfusion and 0.3 percent without. The number needed to treat was 196 to prevent one case of severe morbidity including transfusion, and 311 without.

Subscribe now

That is a real signal in a very large dataset. It is also a smaller and more specific signal than the framing suggests.

First, the 9-month lag did not produce a statistically significant effect in the changepoint model. Only the 21-month lag did. The authors interpret this as evidence that pre-pregnancy and inter-pregnancy care matter. That interpretation is reasonable. It is also the only interpretation that supports their hypothesis. A different reading is that whatever Medicaid expansion is doing, it is doing it through care before conception, not through prenatal or intrapartum care, which is the period most directly relevant to severe maternal morbidity.

Second, an earlier study by Chatterji and colleagues, using Healthcare Cost and Utilization Project data combined with birth certificates, found no effect of Medicaid expansion on severe maternal morbidity at all. The current paper handles this disagreement by pointing out that birth certificates underreport morbidity and do not reliably identify Medicaid coverage. Both points are valid. They also do not resolve the fact that two large analyses of overlapping populations reached opposite conclusions, which should make any reader cautious before declaring a settled finding.

Third, the paper excluded Maryland because the data were anomalous. That is defensible. It also illustrates how fragile state-level Medicaid claims data can be.

None of this argues against expanding coverage. It argues against treating a 0.3 to 0.5 percent absolute risk reduction in one analysis, contradicted by another, as evidence that the structural debate is settled.

The rest of this post is for paid subscribers.

Read more

The paper focuses on neurodivergent pregnant women, including those with autism, ADHD, sensory processing differences, learning disorders, developmental coordination disorder, or Tourette syndrome. Its central point is simple: the goal is not to diagnose neurodivergence in the obstetric office. The goal is to identify how a patient receives information, processes stress, tolerates touch, and participates in time-sensitive decisions.

The paper emphasizes that pregnancy and labor are sensory-intensive experiences. Fetal monitoring, cervical exams, venipuncture, ultrasound, alarms, bright lights, repeated touch, urgent explanations, and unfamiliar staff can overwhelm patients whose processing needs are not recognized. What may look like anxiety, refusal, distrust, “noncooperation,” or poor motivation may instead reflect a mismatch between standard obstetric communication and the patient’s processing style.

The proposed solution is practical. Clinicians should ask early about communication preferences, written versus verbal instructions, sensory triggers, processing time, warning before touch, and the role of a support person.

These needs should be documented in a brief communication care plan, visible to the labor and delivery team, and included in handoffs. During labor, clinicians should use plain language, give one instruction at a time, allow processing time, warn before examinations, reduce unnecessary stimulation when safe, involve the support person, and use teach-back to confirm understanding.

This approach is especially important during urgent intrapartum decisions, when complex explanations may delay consent or worsen distress. In emergencies, the paper recommends direct, concrete statements: problem, action, reason. Details can be reinforced afterward with written summaries.

The evidence base remains limited and is drawn largely from qualitative studies and patient-reported experiences rather than randomized obstetric outcome trials.

Still, the clinical logic is strong. Better communication is not a separate program. It is basic obstetric safety adapted to patients whose needs have too often been missed.

A care gap is not a lack of knowledge. It is a failure to apply what we already know, consistently, to the patient in front of us.

A woman has preeclampsia. She delivers. She is discharged. Six weeks later, she is told she looks well. Years later, she presents with advanced kidney disease. No one made an obvious mistake. The system performed exactly as designed. That is the problem.

The evidence is not unclear. Pregnancy complications such as preeclampsia are long-term risk markers for chronic disease, including kidney disease. Screening exists. It is simple. It is inexpensive. It is not being done. This is not a knowledge gap. It is a reliability failure.

We rely on memory. That is unsafe.

Clinicians are busy, interrupted, and managing competing priorities. Even excellent clinicians will not reliably connect a pregnancy complication from ten years ago to a silent long-term risk today. That is not negligence. It is a structural limitation.

AI changes this immediately.

Not by replacing clinicians. By enforcing consistency where humans cannot.

AI does what guidelines cannot do on their own. It operationalizes them.

It identifies patients with prior preeclampsia from the record. It keeps that risk visible across time. It prompts the clinician at the point of care. It links that prompt to the correct tests. It does this every time, for every patient, without fatigue.

This is not innovation. It is basic systems engineering applied to medicine.

If a system allows a known 5- to 9-fold risk signal to disappear after discharge, that system is defective.

What implementation looks like now and where patients can help themselves:

The rest of this post is for paid subscribers.

Read more

The United States and Germany both practice advanced medicine. Yet the organization of care, the role of physicians, and the structure of prenatal services reveal two very different medical cultures.

At first glance, medicine in the United States and Germany looks remarkably similar. Both countries train highly skilled physicians, rely on modern hospitals, and practice evidence-based medicine. Yet beneath that shared scientific foundation lies a system shaped by very different structures, professional roles, and expectations about how care should be delivered.

Even the language of medicine reflects the difference. In the United States physicians in training are residents, supervised by attendings.

In Germany they are Assistenzärzte, supervised by Fachärzte or Oberärzte, with department leaders called Chefärzte.

American hospitals speak of labor and delivery units, emergency departments, and attendings.

German hospitals refer to Kreißsäle, Notaufnahmen, and Dienstärzte. The terminology signals different professional hierarchies and different traditions in how authority is structured within hospitals.

Prenatal care also begins in different places.

In Germany most pregnant women receive routine prenatal care from community-based office obstetricians or gynecologists (Frauenärzte). These physicians typically operate in private outpatient practices and follow standardized national prenatal care schedules. Insurance coverage is nearly universal through statutory health insurance or private insurance, so access to prenatal visits, ultrasounds, and laboratory testing is rarely limited by coverage status.

All patients in Germany can see a doctor in her practice

In the United States the situation is more fragmented. Prenatal care depends heavily on insurance status. Some pregnant women receive care through private insurance plans with broad access to specialists and imaging. Others rely on Medicaid, which finances a large share of births but varies by state in provider participation and reimbursement.

There is rarely a private physician in the US seeing a Medicaid patient in her practice

A smaller group of women begins pregnancy without insurance and may delay care until Medicaid eligibility is established or until they reach hospital systems that provide safety-net services.

Insurance also influences where women give birth in the United States.

Some hospitals predominantly serve privately insured patients, while others function as safety-net institutions caring for large Medicaid or uninsured populations. As a result, the distribution of obstetric patients across hospitals often mirrors the structure of the insurance system itself.

Germany operates differently.

Nearly all residents are insured through a universal system of statutory health insurance funds. Hospitals generally care for patients regardless of insurance fund membership, and pregnant women are usually directed to hospitals based on geography, physician referral, or patient preference rather than insurance status.

Hospital labor care reflects additional differences. In Germany, as in much of Europe, midwives play a central role in labor management. Physicians are present for complications, operative deliveries, and surgical care, but routine labor is frequently managed by midwives. German hospitals also commonly provide extended postpartum inpatient stays, historically several days after delivery.

In the United States obstetric care is typically organized around physician-led teams supported by labor nurses, anesthesiologists, and neonatal specialists. Postpartum stays tend to be shorter, and hospital throughput pressures are greater.

These structural differences occur alongside differences in national outcomes. Maternal mortality is substantially higher in the United States than in Germany. Recent national statistics report maternal mortality ratios in the United States of roughly 20 to 30 deaths per 100,000 live births, depending on the year and methodology, while Germany reports approximately 3 to 7 deaths per 100,000 births. Neonatal mortality is also somewhat higher in the United States, although the difference is smaller.

Interpreting these differences is complex. Maternal mortality reflects not only hospital care but also population health factors such as chronic disease, obesity, maternal age, access to prenatal care, and social determinants of health. Differences in how deaths are reported and classified may also influence comparisons between countries.

Both systems therefore show strengths and tensions.

Germany offers near universal coverage, strong outpatient prenatal care networks, and relatively consistent access to maternity services.

The United States offers rapid access to advanced subspecialty care and technological innovation, but access to routine prenatal services can vary depending on insurance coverage and regional resources.

The deeper difference is philosophical. German medicine developed within a regulated insurance framework designed to guarantee coverage for the entire population. American medicine evolved through a complex mix of private insurance, employer-based coverage, public programs such as Medicaid and Medicare, and hospital-based care systems.

These historical choices still shape clinical practice today.

Spend time in a German maternity clinic and then walk through an American labor unit. The science of obstetrics is the same. The textbooks are the same.

But the organization of care feels different. And outcomes are very different. More than fives times more women die in the US in and after pregnancy.

Sometimes profoundly so.

Medicine in the United States and the United Kingdom appears similar on the surface. Both countries train highly skilled physicians, rely on scientific evidence, and care for patients within advanced hospital systems. Yet beneath that shared vocabulary lies a striking cultural divide.

Much like the linguistic differences between American and British English, the practice of medicine in the two countries reflects very different assumptions about authority, responsibility, and the role of the physician.

Even the language of medicine reveals the divide.

In the United States, a physician in training is called a resident, and a fully independent physician is an attending.

In the United Kingdom, since 2024, the term “resident doctor” is used for all doctors in postgraduate training, including both foundation doctors and specialty trainees, while the fully trained physician is called a consultant, equivalent to a US attending. Despite the shared term, a UK “resident doctor” spans a broader range of training stages than a US resident and is not a direct one-to-one equivalent.

An American patient goes to the emergency department, while in Britain the same patient goes to A&E. These differences may seem cosmetic, but they reflect different professional hierarchies and expectations about who ultimately carries responsibility for decisions.

The differences become even clearer on the hospital floor. In the United States obstetric care is typically delivered by a team that includes physicians, labor nurses, anesthesiologists, and neonatal specialists. Nurses play a central role during labor, continuously monitoring patients and assisting physicians.

In many British maternity units the structure is different. Midwives are the primary professionals managing labor, often working independently, and physicians such as registrars or consultants are called when complications arise.

In general, physicians in British obstetric units do not have dedicated labor nurses assisting them in the same way American obstetricians do.

The contrast begins even earlier, during prenatal care. In Britain nearly all pregnant women receive care through the National Health Service. Prenatal visits, laboratory tests, ultrasound examinations, and delivery care are covered within a unified national system. Patients typically follow standardized care pathways coordinated by midwives and hospital-based obstetric services.

In the United States prenatal care depends heavily on insurance status. Some pregnant women receive care through private insurance plans, often with relatively broad access to specialists and imaging. Others rely on Medicaid, which finances a large share of births in the United States but varies widely by state in provider participation and coverage policies.

A smaller but important group of women begins pregnancy with no insurance at all, sometimes delaying prenatal care until Medicaid eligibility is established or until they present to hospital systems that provide safety-net services.

Subscribe now

This difference shapes the experience of pregnancy. In Britain the question is rarely whether prenatal care will be covered. In the United States the question often becomes where that care will occur, which clinicians accept the insurance plan, and whether administrative barriers delay access to services.

The most obvious difference between the two systems remains structural. British medicine operates largely through the National Health Service. Physicians function inside a national system where access, resources, and clinical pathways are heavily standardized. American medicine developed in a more decentralized environment. Hospitals, insurers, and physician groups interact in a complex marketplace rather than within a single national framework.

This difference shapes clinical behavior. In the United Kingdom care is often organized around system stewardship. Guidelines and care pathways frequently determine what happens next.

In the United States physicians historically retained more individual authority in clinical decision making, even as administrative oversight and insurance constraints continue to grow.

The contrast is especially visible in obstetrics. American obstetrics traditionally emphasizes physician responsibility for individual outcomes. A clinician managing labor often carries personal legal and professional accountability for decisions made in that room. In the United Kingdom responsibility is more distributed across teams and systems of care, including a stronger institutional role for midwifery services.

Communication styles also diverge.

British medical culture tends to favor understatement, indirectness, and institutional language. American medicine often communicates more explicitly about risk, intervention, and individual decision making.

These differences can influence how clinicians frame uncertainty, how patients perceive autonomy, and how professional authority is exercised.

None of this means one system is inherently superior. Each reflects the history, law, and culture that produced it. British medicine grew inside a national health service designed after World War II to guarantee universal access. American medicine developed through a patchwork of private practice, academic centers, and insurance markets.

Yet the deeper question is philosophical. What does society expect a physician to be?

In Britain the physician often functions as a steward of public resources within a coordinated national service. In the United States the physician historically acted as an independent professional responsible primarily to the patient in front of them.

That difference still shapes attitudes toward guidelines, innovation, and clinical autonomy.

The irony is that both systems are changing. British physicians increasingly face workforce shortages and resource constraints within the NHS. American physicians increasingly practice within large health systems where administrative rules influence clinical choices.

In other words, the two traditions may slowly be converging.

Still, the cultural differences remain unmistakable. Spend time in a British hospital ward and then walk through an American labor unit. The language is the same. The textbooks are the same. The science is the same.

But the practice of medicine feels different.

Sometimes profoundly so.

LinkedIn tagline:
Two countries. Same science. Very different cultures of obstetric care.

Hashtags:
#Obstetrics #MedicalEthics #NHS #USHealthcare #HealthSystems #ClinicalResponsibility #ObstetricIntelligence

16:9 Image Prompt:
Split image of two maternity care settings. Left side shows a modern American labor and delivery unit with obstetricians and nurses reviewing fetal monitoring. Right side shows a British NHS maternity ward where midwives manage labor while a consultant obstetrician reviews a chart. Subtle visual cues of the US and UK flags in background lighting, clean professional hospital environment, editorial illustration style, soft natural light.

and add a couple sentences about division of care by insurances for hospitals too

Two Nations Divided by a Common Language. And Sometimes by a Health System.

Subtitle: The United States and the United Kingdom both practice modern medicine. Yet their cultures of care, responsibility, and decision making often feel like two professions separated by the same language.

Series: The Obstetric Intellect
Where ideas, evidence, and ethics meet to challenge assumptions in obstetrics.

Medicine in the United States and the United Kingdom appears similar on the surface. Both countries train highly skilled physicians, rely on scientific evidence, and care for patients within advanced hospital systems. Yet beneath that shared vocabulary lies a striking cultural divide. Much like the linguistic differences between American and British English, the practice of medicine in the two countries reflects very different assumptions about authority, responsibility, and the role of the physician.

Even the language of medicine reveals the divide. In the United States a young physician is a resident. In Britain the equivalent doctor is a registrar or senior house officer, and the senior physician is called a consultant, rather than an attending. An American patient goes to the emergency department, while in Britain the same patient goes to A&E. These differences may seem cosmetic, but they reflect different professional hierarchies and expectations about who ultimately carries responsibility for decisions.

The differences become even clearer on the hospital floor. In the United States obstetric care is typically delivered by a team that includes physicians, labor nurses, anesthesiologists, and neonatal specialists. Nurses play a central role during labor, continuously monitoring patients and assisting physicians. In many British maternity units the structure is different. Midwives are the primary professionals managing labor, often working independently, and physicians such as registrars or consultants are called when complications arise. In general, physicians in British obstetric units do not have dedicated labor nurses assisting them in the same way American obstetricians do.

The contrast begins even earlier, during prenatal care. In Britain nearly all pregnant women receive care through the National Health Service. Prenatal visits, laboratory tests, ultrasound examinations, and delivery care are covered within a unified national system. Patients typically follow standardized care pathways coordinated by midwives and hospital-based obstetric services.

In the United States prenatal care depends heavily on insurance status. Some pregnant women receive care through private insurance plans, often with relatively broad access to specialists and imaging. Others rely on Medicaid, which finances a large share of births in the United States but varies widely by state in provider participation and coverage policies. A smaller but important group of women begins pregnancy with no insurance at all, sometimes delaying prenatal care until Medicaid eligibility is established or until they present to hospital systems that provide safety-net services.

Insurance also shapes where women give birth. In the United States hospitals often have different patient mixes depending on the insurance coverage they accept. Some hospitals predominantly serve privately insured patients, while others function as safety-net institutions caring for large Medicaid or uninsured populations. As a result, the distribution of obstetric patients across hospitals can mirror the structure of the insurance system itself.

In Britain such financial sorting rarely occurs. Because the NHS finances maternity care nationally, pregnant women are generally directed to hospitals based primarily on geography and service capacity rather than insurance status.

The most obvious difference between the two systems remains structural. British medicine operates largely through the National Health Service. Physicians function inside a national system where access, resources, and clinical pathways are heavily standardized. American medicine developed in a more decentralized environment. Hospitals, insurers, and physician groups interact in a complex marketplace rather than within a single national framework.

This difference shapes clinical behavior. In the United Kingdom care is often organized around system stewardship. Guidelines and care pathways frequently determine what happens next. In the United States physicians historically retained more individual authority in clinical decision making, even as administrative oversight and insurance constraints continue to grow.

The contrast is especially visible in obstetrics. American obstetrics traditionally emphasizes physician responsibility for individual outcomes. A clinician managing labor often carries personal legal and professional accountability for decisions made in that room. In the United Kingdom responsibility is more distributed across teams and systems of care, including a stronger institutional role for midwifery services.

Communication styles also diverge. British medical culture tends to favor understatement, indirectness, and institutional language. American medicine often communicates more explicitly about risk, intervention, and individual decision making. These differences can influence how clinicians frame uncertainty, how patients perceive autonomy, and how professional authority is exercised.

None of this means one system is inherently superior. Each reflects the history, law, and culture that produced it. British medicine grew inside a national health service designed after World War II to guarantee universal access. American medicine developed through a patchwork of private practice, academic centers, and insurance markets.

Yet the deeper question is philosophical. What does society expect a physician to be?

In Britain the physician often functions as a steward of public resources within a coordinated national service. In the United States the physician historically acted as an independent professional responsible primarily to the patient in front of them.

That difference still shapes attitudes toward guidelines, innovation, and clinical autonomy.

The irony is that both systems are changing. British physicians increasingly face workforce shortages and resource constraints within the NHS. American physicians increasingly practice within large health systems where administrative rules influence clinical choices.

In other words, the two traditions may slowly be converging.

Still, the cultural differences remain unmistakable. Spend time in a British hospital ward and then walk through an American labor unit. The language is the same. The textbooks are the same. The science is the same.

But the practice of medicine feels different.

Sometimes profoundly so.

The survey never defined AI. Not once.

This is not a minor oversight. It is the whole problem.

What Is AI, Exactly?

Artificial intelligence is not one thing. It is a broad category that includes tools so different from each other that lumping them together is like asking whether Americans trust “medicine” and then drawing conclusions about surgery.

A large language model, or LLM, is a system trained on vast amounts of text that can read, write, reason, and respond in natural language. ChatGPT is an LLM. The AI that helped a patient understand her lab results last week is an LLM. The tool I use to review evidence and write for this publication is an LLM.

A diagnostic algorithm is something else entirely. It is a set of rules or a statistical model trained on specific clinical data to flag a pattern: this imaging scan looks like cancer, this fetal heart rate tracing warrants attention, this lab value is outside the safe range. These systems do not read or write. They match patterns.

An administrative AI is different again. These are the tools that process insurance claims, predict patient no-shows, flag billing codes, and in some notorious cases, deny Medicare coverage at scale. One such system was found to have a 90% error rate in its denials, while the company relied on patients being too sick or too overwhelmed to appeal. That is not a technology story. That is an accountability story. But it gets filed under AI.

An AI scribe is yet another category: a tool that listens to a clinical encounter and generates a note. Some of these are genuinely useful. Some have been documented to introduce errors in up to 70% of the notes they produce. In some systems, those errors are not preserved in the chart, which means the evidence you would need to audit the tool disappears with each encounter.

These are not four versions of the same thing. They are four different technologies with different architectures, different failure modes, different use cases, and different standards of evidence for deployment. Asking the public whether they trust AI without distinguishing between them is not a survey. It is a word association test.

Definition Is Not Bureaucracy. It Is Science.

In medicine, we do not publish a study on “drugs” and draw conclusions about all pharmacology. We specify the agent, the dose, the mechanism, the population, the outcome. The precision is not pedantry. It is what makes the finding mean something. Without it, you have noise, not evidence.

The same standard applies here. When a critic says AI is dangerous in healthcare, the first question should be: which AI, in which clinical context, deployed how, with what safeguards, and evaluated against what outcome? When a proponent says AI will transform medicine, the same questions apply.

Conflation is not neutral. It does real damage. When a claims-denial algorithm with a 90% error rate gets bundled into the same conversation as an LLM helping a patient prepare questions for her oncologist, both tools get tarred with the same brush. The failures of one become the assumed failures of all. And the genuinely useful tools get caught in a backlash they did not earn.

The reverse is also true. When AI proponents point to impressive diagnostic accuracy in radiology research, they are describing a narrow, well-validated tool in a specific domain. Using that success to defend the unmonitored rollout of AI scribes to 600 health systems is not an argument. It is a sleight of hand.

What the Survey Actually Tells Us

The Ohio State survey found that 51% of adults used AI to make an important health decision without consulting a physician. This number should give us pause, but not for the reasons most commentators cited. The worry is not that patients used AI. The worry is that no one knows which AI, for which decision, with what quality of information, and with what outcome.

The finding that 62% use AI to understand symptoms before seeking care is, depending on the tool and the symptom, either reassuring or concerning. A well-designed LLM helping a patient decide whether chest pain warrants an emergency room visit is not the same as an unvetted chatbot telling a pregnant woman her elevated blood pressure is nothing to worry about. The survey cannot tell us which world we are living in, because it never asked.

This is not a critique of the researchers. It is a critique of the discourse. We have built an entire public debate around a word that nobody has agreed to define. And then we wonder why trust is sliding.

My Take

I have spent the last year pushing my colleagues to take LLMs seriously as clinical and intellectual tools. I have published on it. I have argued that the physician who refuses to learn this technology is making the same mistake as the physician who refused to look through Semmelweis’s microscope. I stand by that position.

But I am equally impatient with the AI critics who write screeds against a word. If your argument is that AI is dangerous in healthcare, you owe your readers a sentence that begins: specifically, I mean.

An LLM with no clinical validation deployed without physician oversight? Say that.

A claims-denial system trained to minimize payouts at the expense of sick patients? Say that.

A diagnostic algorithm validated in one population and sold to another? Say that.

Precision is not a technicality. It is the difference between evidence and noise. The public’s trust is slipping not because they understand AI and reject it. It is slipping because they are watching a field deploy tools faster than it can explain them, and no one in a position of authority is offering definitions, standards, or accountability.

You cannot hold something accountable that you cannot define. That goes for the technology. And it goes for the people writing about it.

Summary

A 30-year-old man posted to r/relationship_advice after his wife tested positive for both bacterial vaginosis and chlamydia. The wife offered two possible explanations: her husband had been unfaithful, or she had contracted chlamydia by borrowing an unwashed sex toy from a female friend in December. The husband, who reported his own symptoms consistent with chlamydia, was awaiting his own test results. The post received 2,700 upvotes and 1,400 comments. What made this post clinically important was not the relationship drama -- it was the flood of biomedical misinformation that followed. Commenters confidently stated that BV cannot cause a false positive, that chlamydia cannot be transmitted via sex toys, and that dormancy lasting years is impossible. All three assertions are partially or completely wrong. The post is a window into how poorly the public understands chlamydia biology -- and how poorly we, as clinicians, have communicated it.

The rest of this post is for paid subscribers.

Read more

I have been writing about what medical television gets wrong. “The Pitt” romanticizes the heroic doctor. The beautiful labor and delivery unit across the street from its own hospital gets a flattering profile in The Cut. In both cases, the surface looks good and the system underneath does not get examined.

So let me tell you about a show that gets it right.

What Is “Malpractice”?

“Malpractice” is a British medical thriller on ITV, now in its second season. It was written by Grace Ofori-Attah, who was a doctor in the NHS for fifteen years before becoming a screenwriter. That background shows in every scene.

Season one followed an A&E doctor whose career unravels after a patient dies under her care. Season two moves to a psychiatric unit. A registrar named Dr. James Ford is pulled in two directions during an impossibly busy on-call shift: a new mother at a postnatal check-up showing signs of distress, and a woman in florid psychosis who needs to be sectioned immediately. He makes a choice. The consequences are devastating.

But here is the thing. “Malpractice” is not really about Dr. Ford. It is about what happens after.

The Medical Investigation Unit

The heart of the show is the Medical Investigation Unit -- the MIU. Two doctors, Dr. Norma Callahan and Dr. George Adjei, are brought in from outside the hospital to investigate what happened. They are independent. They have no loyalty to the institution, no stake in protecting anyone’s reputation, and no reason to look the other way.

What they find in season two is not a bad doctor. They find a broken system. A hospital running on empty. Incident reporting far below the actual number of near-misses. A culture of bullying and cover-ups in which staff are too afraid to speak. Senior administrators more focused on keeping the hospital solvent than keeping patients safe. And at the center of it all, a psychiatric unit that the trust was quietly planning to shut down entirely.

Dr. Ford was not the cause. He was the symptom.

Subscribe now

Why This Matters

In American medicine, we have no equivalent of the MIU. When something goes wrong in a hospital, the internal review process is run by the same institution that has the most to lose from the truth coming out. Morbidity and mortality conferences are valuable, but they are conducted by colleagues, in-house, with no independent oversight and no obligation to act on what they find.

The result is predictable. Bad systems get protected. Individual doctors get blamed. The same errors happen again.

I have spent years arguing for an NTSB-style model in obstetrics -- an independent body that investigates adverse outcomes the way the National Transportation Safety Board investigates plane crashes. Not to assign blame. To understand what failed and why, so it does not happen again. The aviation industry transformed its safety record by adopting exactly this approach. Medicine has been much slower to follow.

“Malpractice” dramatizes why that model works. The MIU can go where internal reviewers cannot. They have no relationships to protect, no budget to defend, no political capital at stake. They just follow the evidence. And the evidence, in season two, leads not to a flawed registrar but to a hospital leadership that had been manipulating safety data to hide how dangerous the place actually was.

That is not a fictional scenario. That is real life, written by someone who lived it.

What “The Pitt” Gets Wrong and “Malpractice” Gets Right

“The Pitt” tells you that medicine succeeds or fails based on individual heroism. “Malpractice” tells you that medicine succeeds or fails based on whether the system is honest about its own failures.

One of those stories is more compelling on screen. The other one is true.

The best medical institutions I have seen share one characteristic: they are relentlessly honest about what goes wrong. They do not protect reputations. They do not suppress incident reports. They do not wait for an outside investigation to force the conversation. They build the accountability structure in from the start, because they understand that a cover-up today is a catastrophe tomorrow.

That is the show. That is also the point.

Share

My Take

I rarely recommend television. I am making an exception for “Malpractice.” Watch it not as entertainment but as a case study in what independent oversight looks like when it actually works.

The show was written by a doctor who understood something most screenwriters do not: patients are not saved by extraordinary individuals.

They are saved by ordinary systems that function as designed, and harmed by systems that were never designed to be honest about themselves.

Subscribe now

We need an MIU in American obstetrics. We need an independent body with the authority to investigate adverse maternal and neonatal outcomes, with no institutional loyalties and no political cover to provide. Until we have that, we will keep holding M&M conferences, writing up the individual physician, and wondering why the same things keep happening.

A British television drama figured this out. We should too.

I watched a few episodes of “The Pitt.”

The production is good.

The acting is fine.

The emergency department looks believably chaotic.

Subscribe now

And yet something kept bothering me. It took a while to put my finger on it.

The show is built around a doctor who is brilliant, wounded, overworked, and morally superior to everyone around him. He makes the saves. He carries the weight. He is the reason patients live or die.

That is not medicine. That is mythology.

What makes a great doctor

After 50 years in obstetrics, including running one of the largest labor and delivery units in New York City, I can tell you what actually separates good outcomes from bad ones. It is not the charismatic attending with the backstory. It is systems. Protocols. Checklists. Teams that communicate. Nurses who speak up. Residents who are trained, not heroic. Handoffs that work.

The physician personality cult is one of medicine’s most persistent and dangerous myths. It tells patients that if they find the right doctor, the brilliant one, the dedicated one, the one who really cares, they will be safe. It tells young physicians that excellence is a personality trait rather than a discipline. It tells hospitals that one exceptional individual can compensate for a broken system.

None of that is true. And some of it is actively harmful.

What Hollywood gets wrong

“The Pitt” is well-intentioned. I understand the goal: show the reality of emergency medicine, the burnout, the moral injury, the impossible choices. These are real. They deserve attention.

But the storytelling frame undermines the message. When a show centers outcomes on individual heroism, it reinforces exactly the wrong lesson. The patient who survives does so because of the attending’s extraordinary effort. The patient who dies does so because the system was overwhelmed — but the attending tried his best. The individual is always the unit of analysis.

In reality, the unit of analysis should be the institution. The protocol. The team. When something goes wrong in a well-run hospital, the first question is not “who failed?” It is “what failed?” That distinction is the foundation of every serious patient safety framework we have — from the original Lucian Leape work to the Joint Commission standards to the NTSB model I have adapted for obstetric safety.

Hollywood cannot tell that story because it does not have a face.

Why this matters beyond television

I would leave this as a harmless entertainment complaint except that it has real consequences.

Patients often choose physicians based on charisma, not competence.

I can tell you from experience that the “charismatic” doctor is often not the one with the best outcomes.

Medical culture still rewards the cowboy over the team player. Hospitals still protect the brilliant surgeon who terrorizes the OR rather than the quiet hospitalist who documents everything correctly and never misses a handoff.

“The Pitt” did not create this problem. But it feeds it.

Share

Great medicine looks boring on screen.

A well-designed checklist, followed by every team member, every time, without drama, that is what saves lives.

A standardized handoff protocol that ensures the night team knows exactly what happened during the day, that is what prevents errors.

A culture where the nurse can interrupt the attending without fear, that is what catches the near misses before they become tragedies.

The unit I was in charge of never had a maternal death. In 12 years. That is boring.

Our placenta accretas were routinely handled with a full-team approach. Boring.

The NICU attending complained because there were less NICU admissions and less neonatal cooling because we prevented and treated tachysystole by decreasing oxytocin and not using misoprostol. Not waiting until there was a category 3 tracing. That is really boring.

None of that makes good television.

In fact when a television crew came one day to film, there was no material for them to use. They dropped us and went to another hospital. This disappointed our administration.

I understand. But it is the truth.

A recent article in The Cut

A recent article in The Cut profiled the Claudia Cohen Labor and Delivery unit at NewYork-Presbyterian.

Beautiful facility.

Patients appreciated the environment but complained about wait times. The Cut covered all of it.

What the article did not mention is the one thing that actually matters: the Claudia Cohen L&D is located across the street from the main hospital.

In true major obstetric emergencies, and they happen without warning, immediate access to the full resources of a hospital is not optional. It is the system. And the system has to work. A stunning room means nothing if the infrastructure to handle a sudden catastrophic complication is a street crossing away.

This is exactly what “The Pitt” gets wrong, and what that article in The Cut missed for the same reason: both were looking at the surface.

The charismatic doctor. The beautiful unit. The patient experience score. None of that tells you whether the system works when it has to. Patients choosing where to deliver deserve to know that. Neither Hollywood nor The Cut told them.

My Take

I do not watch medical dramas to feel good about medicine. I watch them to see what story medicine is telling about itself.

“The Pitt” tells the story that doctors have always preferred: the individual hero, defined by effort and personality, standing between the patient and death.

After 50 years, I prefer a different story. Not as cinematic. Considerably more accurate.

The best doctors I have known were not the most dramatic ones. They were the ones who built systems so good that when they were absent, nothing fell apart.

The best doctors were the ones you never heard of, and that were part of the team, that created the safest environment, followed or improved protocols, and had the best outcomes.

That is the show I would watch.

Summary

A first-time mother at 37 weeks and 6 days posted to r/BabyBumps about getting a Brazilian wax before delivery -- and deeply regretting it.

The post got 287 upvotes and 122 comments. Reactions ranged from sympathetic (it hurts even more in pregnancy because blood flow to the skin is dramatically increased) to practical (waxing before delivery can actually make postpartum cleanup easier) to clinical (shaving or waxing near your due date raises your infection risk). What struck me was not the pain story -- that part everyone can figure out the hard way. What struck me was what was missing: evidence-based guidance from clinicians. These women are making decisions that affect surgical site infection rates, and most of them have never been told what the data actually show.

Commentary

What the research actually shows

Pubic hair removal before labor has a long and embarrassing history in obstetric practice. For decades, hospitals routinely shaved laboring women -- not because of evidence, but because it seemed logical. It was not logical. A 2021 Cochrane systematic review of 25 trials with nearly 9,000 participants found that shaving with a razor compared to no hair removal probably increases surgical site infection risk (RR 1.82). In absolute terms, that translates to roughly 17 additional infections per 1,000 cases -- a meaningful number when you scale it to the 3.6 million US births per year, nearly one-third of which are cesarean deliveries.

Clipping, by contrast, appears neutral -- no significant difference in SSI compared with no hair removal. The WHO and SHEA guidelines both recommend against razor shaving before surgical procedures, including cesarean section. StatPearls (NCBI) is explicit: patients should be advised not to shave their pubic area as they approach their due date, because shaving causes microscopic skin breaks that raise infection risk rather than reduce it.

Why waxing near term deserves special caution

Waxing is not exactly the same as shaving -- it removes hair at the root rather than cutting at the surface. However, waxing also causes skin microtrauma, follicular disruption, and temporary breaks in the epithelial barrier. In pregnancy, blood volume increases by 40-50%, driving dramatically higher skin perfusion and sensitivity. Any barrier disruption in a highly vascularized region near the vaginal introitus and perineum creates a more favorable environment for bacterial colonization.

The concern is not theoretical. A quality improvement study at North York General Hospital found that 41% of patients undergoing elective cesarean sections had self-removed pubic or lower abdominal hair before arriving at the hospital -- 83% of them by shaving, the rest by waxing or other methods. When the hospital implemented patient education about not removing hair in the final month of pregnancy, the self-removal rate dropped significantly and the concurrent SSI rate fell by 51%. Causality is hard to establish in a quality improvement design, but the signal is real enough that multiple institutions have adopted formal patient education programs around this.

What doctors are not telling their patients

The Reddit thread is clinically revealing precisely because of what is absent. In 122 comments from real patients, the conversation is dominated by pain tolerance stories, postpartum hygiene preferences, and anecdotes about individual midwives. Almost no one mentions the infection data. One commenter cites a vague “7 days before delivery” rule; another mentions her OB recommended trimming. No one frames it in terms of surgical site infection risk, microtrauma, or the specific recommendations of WHO, Cochrane, or SHEA.

This is a counseling failure. If 41% of patients preparing for cesarean section are still self-removing pubic hair at home -- a behavior associated with increased SSI risk -- it is because the clinical encounter has not made the stakes clear. ACOG’s own patient-facing language says “you don’t need to shave before giving birth” and favors trimming. That is accurate but insufficient. Patients are making active decisions about waxing at 37-38 weeks without knowing that even one week before delivery, a shave or aggressive waxing session could matter to their wound healing. The data exist. The guidelines, to their modest credit, are largely aligned. What is missing is the communication.

What It Means

This Reddit thread is a window into a counseling gap that has real clinical consequences.

Patients are making decisions about pubic hair removal in late pregnancy -- including Brazilian waxes at 37 weeks -- without any understanding of the evidence.

Some of those patients will go on to have cesarean deliveries.

The Cochrane evidence is unambiguous that razor shaving raises SSI risk. The evidence on waxing-related microtrauma is biologically plausible and supported by the NYGH quality improvement data. At minimum, every patient who might deliver by cesarean -- which in practice means every pregnant patient -- should be told clearly and early: in the last month of pregnancy, skip the wax, skip the razor. Trim if you want. The clinical encounter is the right place for this. Reddit is where they are going instead.

My Take

I have delivered more than 10,000 babies. I cannot recall a single prenatal visit where I counseled a patient about pubic hair removal and surgical site infection. That is on me, and on our specialty. We spend enormous energy on birth plans, feeding choices, and epidural preferences -- things that matter but that patients often research themselves. Meanwhile, a behavior that plausibly raises the risk of a postoperative infection after one of the most common surgeries in the United States goes routinely undiscussed.

The 41% self-removal rate before elective cesarean sections at NYGH in 2008 did not happen because patients were being reckless.

It happened because no one told them not to.

The Reddit poster at 37w6d was not making a bad decision by her own lights -- she had read previous posts, consulted community wisdom, and made an informed choice within the information she had. The information she had was incomplete.

The fix is not complicated. It is a paragraph in the prenatal visit, a line in the hospital preparation instructions, a poster in the waiting room. We already know it works -- NYGH showed us that in 2012. Thirteen years later, a first-time mother is still going to a wax salon at 37 weeks and finding out the hard way that pregnancy physiology is not forgiving. We can do better than that.

A nurse calls the attending physician at 2 a.m. She says the tracing looks “a little off.” The physician, half awake and relying on the nurse’s verbal description, says to continue monitoring and call back if things worsen.

Forty minutes later, the baby is born with a severe acidosis.

The tracing, reviewed afterward, showed a clear pattern of accumulating physiologic stress for more than an hour with late decelerations and decreased variability.

The nurse saw it. She was not wrong.

But she did not have the language to say it precisely enough to compel action.

And the physician did not have enough information to recognize the urgency from a description built on vague reassurance.

This is not nevessarily a story about negligence (or maybe it is?). It is a story about what happens when two professionals are trained to use different language to describe the same clinical reality.

Subscribe now

The Shared Framework That Isn’t

Electronic fetal monitoring has been nearly universal in U.S. labor units for decades. The NICHD consensus terminology was introduced to solve exactly this problem: a shared language that would mean the same thing to the nurse at the bedside, the resident on call, and the attending physician reviewing from a distance.

The framework succeeded at standardizing labels. Category I means normal acid-base status is likely. Category III means fetal acidemia is a real concern and demands immediate evaluation. Categories are assigned. Boxes get checked.

But the clinical reality of labor almost never presents at the extremes. The vast majority of concerning fetal heart rate patterns fall into Category II, the deliberately broad middle. And this is where language breaks down between nurses and physicians in ways that have consequences.

A Structural Problem, Not a Personal One

Nurses at the bedside watch the fetal monitor continuously. They see the tracing evolve in real time. They notice that the decelerations were mild an hour ago and are now deeper. They notice that the recovery between contractions is slower than it was. They notice that the baseline has crept up four beats in the last thirty minutes. None of these individual observations crosses a formal threshold. But together, they tell a story.

The physician called from outside the room does not see this evolution.

She receives a verbal report.

And here is the structural problem: nursing education in fetal monitoring traditionally emphasizes pattern recognition within the NICHD classification system. What did the tracing look like at this moment? What category is it?

Physician training, particularly in maternal-fetal medicine, tends to emphasize physiologic interpretation across time. What is happening to this fetus over the course of labor?

These are not the same question. And the language trained for one does not reliably communicate the other.

What you are about to read will change how you walk into your next exam room.

Read more

Reddit is where patients go at 2 a.m. when scared. I monitor dozens of communities for clinically meaningful posts: dangerous myths, gaps between belief and evidence, stories guidelines cannot capture. This series -- ObGyn Intelligence on Reddit -- dissects them against the literature, because ObGyns who ignore social media ignore the most unfiltered wi…

Read more